Publications by authors named "W Chaicumpa"

Background: Cholangiocarcinoma (CCA) is a very aggressive cancer of the bile ducts. Recent advances in immunotherapy, particularly with human single-chain variable fragments (HuScFv), have shown promise in the treatment of solid tumors by targeting cancer cells or improving the immune response.

Objective: This study aimed to select and produce human single-chain antibody fragments (HuScFv) specific to CCA cells (HubCCA1, RMCCA) from phage display HuScFv libraries with minimum or no binding to cholangiocytes (MMNK1).

View Article and Find Full Text PDF

Humans get SARS-CoV-2 infection mainly through inhalation; thus, vaccine that induces protective immunity at the virus entry site is important for early control of the infection. In this study, two anionic liposome (L)-adjuvanted VLP vaccines against SARS-CoV-2 were formulated. Baculovirus-Sf21 insect cell system was used for production of VLPs made of full-length S, M and E proteins.

View Article and Find Full Text PDF

(1) Background: Understanding how advanced cancers evade host innate and adaptive immune opponents has led to cancer immunotherapy. Among several immunotherapeutic strategies, the reversal of immunosuppression mediated by regulatory T cells in the tumor microenvironment (TME) using blockers of immune-checkpoint signaling in effector T cells is the most successful treatment measure. Furthermore, agonists of T cell costimulatory molecules (CD40, 4-1BB, OX40) play an additional anti-cancer role to that of checkpoint blocking in combined therapy and serve also as adjuvant/neoadjuvant/induction therapy to conventional cancer treatments, such as tumor resection and radio- and chemo- therapies.

View Article and Find Full Text PDF
Article Synopsis
  • RNA-dependent RNA polymerase (RdRp) is a promising target for antiviral therapies due to its critical role in RNA virus replication and absence of human equivalents.
  • A newly developed cell-penetrating antibody, PEN-HuscFv34, effectively inhibits replication of various RNA viruses, indicating its potential as a broad-spectrum anti-RNA virus agent.
  • The study introduces a streamlined production method combining Sortase self-cleavage and bacterial surface display to facilitate the large-scale generation of this super antibody, maintaining its antiviral efficacy.
View Article and Find Full Text PDF

Tularemia caused by Gram-negative, coccobacillus bacterium, is a highly infectious zoonotic disease. Human cases have been reported mainly from the United States, Nordic countries like Sweden and Finland, and some European and Asian countries. Naturally, the disease occurs in several vertebrates, particularly lagomorphs.

View Article and Find Full Text PDF